Charlie Stephens
@charlies16.bsky.social
📤 22
📥 147
📝 0
reposted by
Charlie Stephens
Adnan Sharif
3 months ago
The final EpCOT oral presentation from
@charlies16.bsky.social
at
#BTS2026
today was related to PTLD - still the most feared post-transplant cancer. Our analysis shows up-to-date incidence/mortality ratios versus the general population and sub-groups at greater risk.
@btstransplant.bsky.social
0
0
1
reposted by
Charlie Stephens
Adnan Sharif
3 months ago
#2 EpCOT oral from
@charlies16.bsky.social
at
#BTS2026
explores cancer after liver tx in Calle-Williams session. Main findings: ❗️Different SIRs for de novo, second primary and cancer recurrence ❗️Elevated SMRs for all post-tx cancer ❗️HCC recurrence risk is 14%
@btstransplant.bsky.social
0
1
1
reposted by
Charlie Stephens
The British Transplantation Society
3 months ago
Charlotte Stephens shares work on cancer screening in transplant patients and if they should be screened more often than the general population
#btscongress
0
1
1
reposted by
Charlie Stephens
Adnan Sharif
6 months ago
Delighted to see my Commentary published in the latest issue of
#Circulation
Journal Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure Disagree? Happy to be challenged 💪🏼
#StopCardiacTests
Link to issue:
www.ahajournals.org/toc/circ/cur...
loading . . .
Vol 152, No 23 | Circulation
https://www.ahajournals.org/toc/circ/current
0
5
6
you reached the end!!
feeds!
log in